Inhalational Agents

5.2
Inhalational Agents

Nitrous Oxide

  • Clinical Considerations
    • Nonpungent
    • Low blood: gas coefficient allows for titration
  • Cerebral
    • ↑ CMRO2
    • ↑ CBF
  • Cardiovascular
    • Minimal
    • Higher concentrations (>60%) [2]
      • ↑ HR
      • ↑ SV
      • ↑ MAP
    • May attenuate hemodynamic depressant effects of halogenated volatile agents
  • Pulmonary
    • Least effect of the volatile agents
    • ↓ TV
    • ↑ RR
    • No change in minute ventilation unlike other volatile agents
  • Renal
    • Minimal
  • Hepatic
    • Minimal
  • Neuromuscular
    • Not a triggering agent for malignant hyperthermia
  • Contraindications
    • Pneumothorax
    • Small bowel obstruction
    • Otitis media
    • Air embolism
    • First trimester of pregnancy
    • Intraocular surgery with gas bubbles
      • No current guidelines on how long after the eye injection nitrous oxide administration should wait [5]
    • B12 deficiency and methyl tetrahydrofolate reductase deficiency
      • Debatable, but consider avoiding in this population [6]
  • Board Facts
    • Prolonged N2O can cause vitamin B12 deficiency and peripheral sensory and motor dysfunction, especially in chronic nitrous oxide abusers [7]
    • May increase risk of PONV especially at high concentrations [8]
    • Diffuses into endotracheal tube cuff over procedure and can lead to tracheal morbidity [9]
      • Consider inflating cuff with saline instead of air
      Only gold members can continue reading. Log In or Register to continue

Stay updated, free dental videos. Join our Telegram channel

Oct 16, 2024 | Posted by in Oral and Maxillofacial Surgery | Comments Off on Inhalational Agents

VIDEdental - Online dental courses

Get VIDEdental app for watching clinical videos